Top 10 Leading Enterprises in China's Pharmaceutical and Healthcare Industry for 2019 Announced

　　【Pharmaceutical Network Industry Trends] Recently, the list of “2019 China’s Leading Enterprises in Digital Services and Service Outsourcing” was released. Among them, WuXi AppTec, WuXi Biologics, Asymchem, Pharmaron, Novo Nordisk, Covance, BioDuro, Genewiz, Genscript, and JOINN successfully made it onto the top ten list of leading enterprises in the pharmaceutical and healthcare industry.
 

　　WuXi AppTec
 

WuXi AppTec was honored with three titles: “Leading Enterprise in the Pharmaceutical and Healthcare Industry,” “Top 100 Enterprises,” and “Top 10 Leading Enterprises in Service Outsourcing.”
 

Publicly available information indicates that WuXi AppTec has become a comprehensive, R&D-capable, integrated service platform for small-molecule chemical drug discovery, research, and development in China, primarily providing “contract research organization (CRO)” services to pharmaceutical companies both domestically and internationally.
 

It has made substantial investments in research and development. Data shows that WuXi AppTec’s R&D expenditure in the first half of this year reached RMB 178 million, a year-on-year increase of 53.75%, accounting for 4.03% of its operating revenue.
 

　　WuXi Biologics
 

WuXi Biologics was honored with the titles of “Leading Enterprise in the Pharmaceutical and Healthcare Industry” and “Top 100 Enterprises.”
 

Public information shows that WuXi Biologics, the leading CDMO in biologics, covers drug discovery, biologic R&D, and commercial manufacturing, offering integrated solutions.
 

Industry expectations suggest that WuXi Biologics could capture a 15% share of the global biologics contract manufacturing market in 2021, with its revenue reaching approximately USD 3 billion, indicating broad growth prospects.
 

　Asymchem Pharmaceuticals
 

Asymchem Pharmaceuticals has been honored with three titles: “Top 10 Leading Enterprises in Service Outsourcing,” “Leading Enterprise in the Pharmaceutical and Healthcare Industry,” and “Top 100 Enterprises.”
 

Data shows that Asymchem is committed to technological innovation and commercial application of global pharmaceutical processes, serving as a typical enterprise in China's pharmaceutical R&D outsourcing services.
 

In the first half of 2019, the Company maintained a stable growth trend in its performance, achieving a total operating income of RMB 1.093 billion, representing a year-on-year increase of 44.27%; the net profit attributable to shareholders of the listed company amounted to RMB 229 million, representing a year-on-year increase of 46.37%.
 

　Pharmaron
 

Pharmaron was honored with the titles of “Leading Enterprise in the Pharmaceutical and Healthcare Industry” and “Top 100 Enterprises.” Furthermore, Lou Boliang, Chairman of the Board and General Manager of the Company, received the Lifetime Achievement Award for Outstanding Contributions to China’s Digital Services and Service Outsourcing Industry in 2019.
 

Data shows that Pharmaron is a domestic preclinical CRO (contract research organization for small molecule drug development) company in China, providing pharmaceutical companies with preclinical drug development services.
 

From 2014 to 2016, Pharmaron’s global market share in drug discovery CRO services increased from 1.5% to 1.7%, making it the third-largest drug discovery CRO company worldwide.
 

　　Novo Nordisk
 

Novo Nordisk was honored with the title of “Leading Enterprise in the Pharmaceutical and Healthcare Industry.”
 

Public information shows that Novo Nordisk focuses on the medical field and is a global leader in diabetes treatment.
 

　　Covance
 

Covance was honored with the title of “Leading Enterprise in the Pharmaceutical and Healthcare Industry.”
 

Public information indicates that Covance is a globally renowned contract research organization (CRO) for pharmaceutical R&D.
 

　　BioDuro
 

BioDuro Technology was honored with the titles of “Leading Enterprise in the Pharmaceutical and Healthcare Industry” and “Top 100 Enterprises,” while Deng Tianjing, the company’s President and Legal Representative, was recognized as a Leading Figure in the Pharmaceutical and Healthcare Sector.
 

Public information indicates that BioDuro is a globally leading innovative R&D company in the biopharmaceutical industry.
 

　　Genewiz
 

Genewiz Inc.,sz was honored with the titles of “Leading Enterprise in the Pharmaceutical and Healthcare Industry” and “Top 100 Enterprises.”
 

Public information shows that Genewiz is a biotechnology company focused on genomic research and the application of gene technologies.
 

　　GenScript
 

GenScript has been honored with the titles of “Leading Enterprise in the Pharmaceutical and Healthcare Industry” and “Top 100 Enterprises,” demonstrating its strong international competitiveness.
 

Publicly available information indicates that GenScript is a contract research organization (CRO) specializing in biopharmaceutical R&D services. Data show that in the CRO sector, GenScript leads globally with a 30.18% market share.
 

　　JOINN
 

JOINN was honored with the titles of “Leading Enterprise in the Pharmaceutical and Healthcare Industry” and “Top 100 Enterprises.”
 

Publicly available information indicates that JOINN is primarily engaged in preclinical drug research services, with a focus on non-clinical safety evaluation of drugs, as well as the sale of laboratory animals and related products. Additionally, the company provides a limited range of pharmaceutical R&D outsourcing services and related technical support, including drug discovery research such as drug screening, clinical trials, and regulatory and policy consulting.